2007
DOI: 10.1159/000112846
|View full text |Cite
|
Sign up to set email alerts
|

Stem Cell Differentiation: Cardiac Repair

Abstract: Cellular transplantation has been employed for several years to deliver donor cardiomyocytes to normal and injured hearts. Recent reports of a variety of stem cells with apparent cardiomyogenic potential have raised the possibility of cell transplantation-based therapeutic interventions for heart disease. Here we review the preclinical studies demonstrating that intracardiac transplantation of skeletal myoblasts, cardiomyocytes and cardiomyogenic stem cells is feasible. In addition, recent clinical studies of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 142 publications
(65 reference statements)
1
18
0
1
Order By: Relevance
“…Researchers speculate that regenerating zebra fish myocardium also arises from undifferentiated cardiac progenitors (Lepilina et al 2006). The discovery of these preexisting stem/progenitor cells offers a great opportunity to regenerate the lost cardiomyocytes (Murry et al 2005;Srivastava and Ivey 2006;Rubart and Field 2008). However, besides the activation of these residential undifferentiated stem/progenitor cells (dedifferentiation-independent regeneration), a trace of another mechanism of tissue regeneration may also take place in the heart: mature cells dedifferentiate, reenter the cell cycle, and redifferentiate another mature cell type (dedifferentiation-dependent mechanism).…”
Section: Retrodifferentiationmentioning
confidence: 99%
“…Researchers speculate that regenerating zebra fish myocardium also arises from undifferentiated cardiac progenitors (Lepilina et al 2006). The discovery of these preexisting stem/progenitor cells offers a great opportunity to regenerate the lost cardiomyocytes (Murry et al 2005;Srivastava and Ivey 2006;Rubart and Field 2008). However, besides the activation of these residential undifferentiated stem/progenitor cells (dedifferentiation-independent regeneration), a trace of another mechanism of tissue regeneration may also take place in the heart: mature cells dedifferentiate, reenter the cell cycle, and redifferentiate another mature cell type (dedifferentiation-dependent mechanism).…”
Section: Retrodifferentiationmentioning
confidence: 99%
“…Embryonic stem cells (ESCs) have the potential to differentiate into various cell types, including endothelial cells, making them useful for studying vasculogenesis, embryo development and pharmacology (Huang et al, 2010;Joo et al, 2011;). However, although there are a considerable number of reports pointing to potential therapeutic applications of EPCs in the treatment of a wide range of cardiovascular disorders from animal studies and pilot clinical trials (Lipinski et al, 2007;Rubart and Field, 2008), the exact mechanisms underlying the process of ESC differentiation remain obscure and many obstacles must be overcome before clinical application of ESC derived-endothelial cells can be realized.…”
Section: Introductionmentioning
confidence: 99%
“…Recently established induced pluripotent stem (iPS) cells are considered to be the most useful cell sources because they are autografts with a high ability to differentiate, similar to embryonic stem (ES) cells (4,5) . Adult somatic stem cells have also gained attention, and bone marrow stem cells are being clinically studied (6) . Orlic et al (7) fi rst demonstrated that bone marrow stem cells differentiate into cardiac myocytes to repair an infarcted heart.…”
Section: Introductionmentioning
confidence: 99%